Naturis Cosmetics Raises ₹100 Cr for Manufacturing Growth

In a significant move for India's burgeoning beauty manufacturing sector, Naturis Cosmetics, a key player in contract development and manufacturing (CDMO), has successfully closed its inaugural institutional funding round, securing ₹100 crore. The investment, announced on July 16, 2026, was spearheaded by Sharrp Ventures, marking a pivotal moment for the company that has operated for nearly 15 years without external capital.

This substantial capital infusion comes at a time when India's beauty and personal care market is projected to reach an impressive $40 billion by 2030, according to a Redseer report. Naturis Cosmetics, which has been the silent force behind numerous popular brands including Pilgrim, Kay Beauty, and Nykaa's private label, is strategically positioning itself to capitalize on this growth. The company's expertise lies in developing and producing formulations for over 50 beauty brands, a testament to its deep industry integration.

The investor syndicate reflects a strategic alignment with Naturis's growth ambitions. Alongside lead investor Sharrp Ventures, which already holds stakes in Naturis's clients Nykaa and Purplle, the round saw participation from Mirabilis Investment Trust (the family office of Infosys co-founder K. Dinesh), growth-focused firms Anicut Capital and Niveshaay. Additionally, prominent D2C operators like Suyash Saraf (Hyperscale Ventures) and Yogesh Kabra, along with several angel investors from the pharma and specialty chemical sectors, have backed the venture. Sagar Kandhari of Ambassador Capital Partners served as advisor and has joined the board.

Naturis Cosmetics has demonstrated robust financial performance, reporting revenues of ₹155 crore in FY25, a significant leap from ₹43 crore four years prior. This represents a five-year revenue compound annual growth rate (CAGR) of 52%, according to Tracxn data. Crucially, the company has maintained profitability throughout this scaling period, a rare feat for a manufacturing entity experiencing such rapid expansion. While FY22 saw an outlier net profit of ₹28.1 crore, the core business has consistently delivered, with FY25 net profit standing at ₹12 crore on ₹155 crore in sales, yielding a net margin of approximately 7.7%.

The newly acquired capital is earmarked for ambitious expansion plans. Naturis intends to establish a new, expansive 225,000 sq ft production facility in Vapi, augmenting its existing 200,000 sq ft capacity. Furthermore, the company plans to launch a new R&D center in Mumbai and an experience center in the NCR region. These investments are geared towards enabling Naturis to enter new product categories over the next five years, including men's grooming, body care, color cosmetics, and fragrances, while also exploring export markets and deepening its involvement in over-the-counter (OTC) pharmaceutical products.

Led by CEO Rahul Tandon, an IIT Delhi alumnus, and supported by COO Nukul Mehra and co-founders Sanjay Mehra and Dhruv Mehra, the Naturis team is focused on building India's premier ODM platform in the beauty, personal care, and cosmetics (BPC) space. This funding round underscores the strategic importance of manufacturing infrastructure in supporting the dynamic growth of India's D2C brand ecosystem, highlighting that enduring value often lies in the foundational elements of production and innovation.